Step by Stepa HemeOncBuddy patient portal

Gemcitabine

Illustration: Gemcitabine

Say it: jem-SITE-uh-been · Brand names: Infugem

Gemcitabine is a chemotherapy medicine that blocks cancer cells from making the DNA they need to grow.

What it is

Gemcitabine looks like one of the building blocks of DNA. Cancer cells take it in and use it by mistake. This stops them from making new DNA, and they die.

Often used for

How you get it

Gemcitabine is given through a vein (IV) over about 30 minutes. It is often given once a week for 2 or 3 weeks, then a week off. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Gemcitabine?
Gemcitabine is a chemotherapy medicine that blocks cancer cells from making the DNA they need to grow. Brand names: Infugem.
What is Gemcitabine used for?
pancreatic cancer; lung cancer; breast cancer; ovarian cancer; bladder cancer; and some other cancers.
How is Gemcitabine given?
Gemcitabine is given through a vein (IV) over about 30 minutes. It is often given once a week for 2 or 3 weeks, then a week off. Your schedule may be different.
What are the common side effects of Gemcitabine?
Low blood counts, which raise your risk of infection, bleeding, and tiredness. Feeling tired. Nausea and vomiting. Flu-like feelings, such as fever, chills, and aches, for a day or so. Rash. Swelling in the legs or feet. Mild hair thinning.
When should I call my care team while taking Gemcitabine?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills that does not go away within a day; Shortness of breath or a new cough; Passing much less urine, or pink or dark urine; Sudden swelling or fast weight gain; A severe headache, confusion, or vision changes; Bleeding or bruising that will not stop, black or bloody stools, or blood in your urine.
Which chemotherapy plans include Gemcitabine?
Gemcitabine and cisplatin, Gemcitabine and nab-paclitaxel, R-GemOx.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.